Next Article in Journal
Routes of Administration of Illicit Drugs among Young Swiss Men: Their Prevalence and Associated Socio-Demographic Characteristics and Adverse Outcomes
Previous Article in Journal
The Influence of Social Capital on Youths’ Anti-Epidemic Action in the Field of Epidemic-Preventative Social Distancing in China
Article

Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain

1
Department of Psychology, University of Balearic Islands (UIB), 07122 Palma, Spain
2
Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain
3
Mallorca Cancer Registry, Balearic Islands Public Health Department, 07010 Palma, Spain
4
Tarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Hospital Universitari Sant Joan de Reus, Institut d’Investigació Sanitària Pere Virgili (IISPV), 43204 Reus, Spain
*
Author to whom correspondence should be addressed.
Academic Editor: Subas Neupane
Int. J. Environ. Res. Public Health 2021, 18(21), 11156; https://doi.org/10.3390/ijerph182111156
Received: 10 September 2021 / Revised: 8 October 2021 / Accepted: 21 October 2021 / Published: 24 October 2021
Studies about the survival of patients with prostate cancer by stage or risk of progression are scarce. The aims of this study were (1) to determine the cause-specific survival by risk in prostate cancer patients in Mallorca diagnosed in the period 2006–2011; (2) to identify the factors that explain and predict the likelihood of survival and the risk of dying from this type of cancer; and (3) to determine the distribution of prostate cancer by risk in the patients in Mallorca diagnosed in the period 2006–2011. Incident prostate cancer cases diagnosed between 2006 and 2011 were identified through the Mallorca Cancer Registry. We collected age; date and method of diagnosis; date of follow-up or death; T, N, M and stage according to the TNM 7th edition; Gleason score; prostate-specific antigen (PSA); histology according to the International Classification of Diseases for Oncology (ICD-O) 3rd edition, comorbidities and treatments. We calculated risk in four categories: low, medium, high and very high. The end point of follow-up was 31 December 2014. Multiple imputation (MI) was performed to estimate cases with unknown risk. We identified 2921 cases. Five years after diagnosis, survival after MI was 89% globally, and was 100% for low-risk cases, 96% for medium risk, 93% for high risk and 69% for very-high-risk cases. Cases with histology other than adenocarcinoma, with high (and especially very high) risk, as well as with systemic, mixed and observation/unspecified treatments had worse prognoses. View Full-Text
Keywords: prostate neoplasm; survival; stage; multiple imputation prostate neoplasm; survival; stage; multiple imputation
Show Figures

Figure 1

MDPI and ACS Style

Montaño, J.J.; Barceló, A.; Franch, P.; Galceran, J.; Ameijide, A.; Pons, J.; Ramos, M. Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain. Int. J. Environ. Res. Public Health 2021, 18, 11156. https://doi.org/10.3390/ijerph182111156

AMA Style

Montaño JJ, Barceló A, Franch P, Galceran J, Ameijide A, Pons J, Ramos M. Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain. International Journal of Environmental Research and Public Health. 2021; 18(21):11156. https://doi.org/10.3390/ijerph182111156

Chicago/Turabian Style

Montaño, Juan J., Antoni Barceló, Paula Franch, Jaume Galceran, Alberto Ameijide, Jaime Pons, and Maria Ramos. 2021. "Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain" International Journal of Environmental Research and Public Health 18, no. 21: 11156. https://doi.org/10.3390/ijerph182111156

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop